Brazil's Ministry of Health has added the fecal immunochemical test (FIT) as the reference exam for colorectal cancer screening in the public health system [1].
This transition to a less invasive method aims to increase early diagnosis rates and improve patient survival by identifying the disease before symptoms appear [2].
The new protocol, implemented through the Sistema Único de Saúde (SUS), targets asymptomatic adults between the ages of 50 and 75 [1]. The FIT test serves as a high-accuracy alternative to more invasive procedures, boasting an assertiveness rate between 85% and 92% [3].
Under the new guidelines, the Ministry of Health recommends that eligible individuals undergo the screening every two years [1]. The initiative is designed to expand access to diagnostics across the entire national territory via the SUS network [1].
Health officials said the test was incorporated in June 2026, with broad dissemination of the program occurring this month [1]. By replacing more invasive primary screenings with the FIT method, the government intends to lower barriers to patient compliance and increase the volume of early-stage detections [2].
Colorectal cancer remains a significant public health challenge. The move to standardize the FIT test across the public network allows for a more streamlined referral process for patients who test positive and require further diagnostic imaging, or colonoscopies [3].
“The FIT test serves as a high-accuracy alternative to more invasive procedures.”
The adoption of the FIT test represents a shift toward preventative, low-barrier screening in Brazil's public health infrastructure. By targeting the 50-to-75 age bracket with a non-invasive tool, the government is attempting to reduce the long-term cost of cancer treatment by catching malignancies in treatable stages, potentially reducing the burden on specialized surgical centers.
